The growing old age population and advancements in head and neck cancer diagnostics technology are augmenting the growth of the global head and neck cancer diagnostics market in the forecast period, 2023-2027.
According to TechSci Research report, “Head and Neck Cancer Diagnostics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global head and neck cancer diagnostics market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027. Head and Neck cancer can be defined as the numerous types of malignant tumors grown around the head and neck. They begin in squamous cells that line the mucosal surface of the head and neck, which is referred to as squamous cell carcinoma. This cancer is among the ten most common types of cancers worldwide and is especially prevalent in regions where alcohol and tobacco consumption are high.
The global head and neck cancer diagnostics market is expected to grow in the upcoming years at a rapid rate. The growing number of cases of chronic diseases and the rising number of diagnostic procedures for head and neck cancer are among the primary factors driving the global head and neck cancer diagnostics market. Along with this, government bodies and various private organizations are taking healthcare initiatives to make people aware people about the preventive measures for chronic diseases like head and neck cancer.
Head and neck cancers usually affect the oral cavity, paranasal sinuses, pharynx, larynx, nasal cavity, and salivary glands. At present, immunotherapy has been identified as one of the effective techniques for cancer treatment. Numerous immunotherapies, including immune checkpoint inhibitors, have been approved for head and neck cancer treatment, augmenting the global head and neck cancer diagnostics market.
However, the high cost of the testing devices and unfavorable reimbursement of the oncological treatment may restrain the market growth in the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on“Global Head and Neck Cancer Diagnostic Market”
https://www.techsciresearch.com/report/global-head-and-neck-cancer-diagnostic-market/10618.html
The global head and neck cancer diagnostic market is segmented based on type, end user, company, and regional distribution.
Based on the type, the market is divided into diagnostic imaging, biopsy, endoscopy, and dental diagnostics. Diagnostic imaging is projected to account for the highest market share in the upcoming years. Increasing awareness about the benefits of early detection of diseases is propelling the market growth. Increasing concern for the wellbeing of a patient and the escalating demand for effective treatment procedures at any cost is accelerating the growth of the head and neck cancer diagnostic market. Numerous initiatives are being taken by the government bodies to lower the cost of oncological treatment in hospitals.
Based on the end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. Hospitals are anticipated to capture the largest market share in the forecast period. Hospitals offer required facilities to the patients to treat the patients with quality care. Along with this, hospitals focus on providing all kinds of diagnostic with advanced equipment and novel technologies.
Based on regional analysis, the North American region is expected to dominate the global head and neck cancer diagnostic market in the forecast period. The early adoption of cancer diagnostics technology by healthcare facilities and the rising number of cancer cases across the United States are propelling the market growth. As per the study done by the American Society of Clinical Oncology (ASCO) in January 2021, head, and neck cancer accounted for about 4% of all cancer types in the United States, which further bolsters the demand for diagnostic imaging in the region.
Leading market players operating in the global head and neck cancer diagnostic market are:
- Addent Inc
- GE Healthcare
- Koninklijke Philips NV
- Shimadzu Corporation
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Canon Medical system Corporation
- Carestream Healthcare Inc.
- Neusoft Medical Systems Co., Ltd.
- Varian Medical Systems, Inc.
Download Sample Report@ https://www.techsciresearch.com/sample-report.aspx?cid=10618
Customers can also request for 10% free customization on this report.
“Continuous technological advancements and product innovations in diagnostic methodology are anticipated to stimulate the global head and neck cancer diagnostic market. In addition to this, extensive research funding by public and private organizations for oncological advancement further supports the market growth. Early diagnosis and advanced treatment facilities allow patients to cure diseases like head and neck cancers, especially oral and pharyngeal cancers. Development of immunotherapies, and CAR-T cell therapies, among others, for cancer treatment and a large patient pool are expected to propel the global head and neck cancer diagnostic market till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Head And Neck Cancer Diagnostic Market – Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics), By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others), By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing), By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy), By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), and By Region”, has evaluated the future growth potential of global head and neck cancer diagnostic market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global head and neck cancer diagnostic market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]